NewSquare Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15
Closed -$1.04K 195
2025
Q2
$1.04K Hold
15
﹤0.01% 1048
2025
Q1
$745 Buy
+15
New +$948 ﹤0.01% 957
2023
Q3
Sell
-10
Closed -$1.83K 596
2023
Q2
$1.83K Sell
10
-18,785
-100% -$2.7M ﹤0.01% 532
2023
Q1
$2.5M Sell
18,795
-16,585
-47% -$1.95M 0.3% 104
2022
Q4
$2.81M Buy
+35,380
New +$2.49M 0.35% 93

Other funds holding ACLS

NewSquare Capital's ACLS Position: Q3 2025 in Review

NewSquare Capital sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 15 shares — an estimated $1.04K sold.

NewSquare Capital first reported a position in ACLS in Q4 2022 and held it in 5 quarters. The position peaked at $2.81M in Q4 2022. 361 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • NewSquare Capital reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 15 Axcelis shares in Q3 2025, an estimated $1.04K.
  • NewSquare Capital first reported a position in Axcelis in Q4 2022 and held it in 5 quarters.
  • NewSquare Capital's Axcelis position peaked at $2.81M in Q4 2022.
  • 361 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.